Close Menu

CHICAGO (GenomeWeb) – At the intersection of genomics and proteomics, investigators are doing basic research bent on improving existing immunotherapies and better understanding response.

Attendees at the American Association for Cancer Research heard about just a few of these potential applications during a major symposium on cancer immunotherapy analyses here yesterday.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.